Clinical Trials Browser

Hematologic Neoplasms × Human Papillomavirus Recombinant Vaccine nonavalent × 90 days × Clear all

NCT03023631 2026-05-20

Gardasil 9 Vaccine in Preventing HPV Infection in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant

Phase 4 Active not recruiting

Other hematologic neoplasm

Hematologic Neoplasms